Goldman Sachs Group Inc Wave Life Sciences Ltd. Transaction History

Goldman Sachs Group Inc

  • $596 Billion
  • Q1 2025

A detailed history of Goldman Sachs Group Inc transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 557,644 shares of WVE stock, worth $3.89 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
557,644
Previous 557,644 -0.0%
Holding current value
$3.89 Million
Previous $4.51 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
BUY
$8.08 - $13.51 $166,641 - $278,630
20,624 Added 3.84%
557,644 $4.51 Million
Q4 2024

Feb 11, 2025
BUY
$8.0 - $16.44 $1.3 Million - $2.67 Million
162,657 Added 43.45%
537,020 $6.64 Million
Q3 2024

Nov 14, 2024
BUY
$5.12 - $9.01 $713,891 - $1.26 Million
139,432 Added 59.35%
374,363 $3.07 Million
Q2 2024

Aug 13, 2024
SELL
$4.38 - $6.48 $463,171 - $685,240
-105,747 Reduced 31.04%
234,931 $1.17 Million
Q1 2024

May 15, 2024
SELL
$3.54 - $6.84 $178,607 - $345,105
-50,454 Reduced 12.9%
340,678 $2.1 Million
Q4 2023

Feb 13, 2024
BUY
$4.16 - $6.87 $205,246 - $338,952
49,338 Added 14.44%
391,132 $1.98 Million
Q3 2023

May 14, 2024
SELL
$3.56 - $5.75 $175,643 - $283,693
-49,338 Reduced 12.61%
341,794 $1.97 Million
Q3 2023

Nov 14, 2023
BUY
$3.56 - $5.75 $842,253 - $1.36 Million
236,588 Added 224.88%
341,794 $1.97 Million
Q2 2023

May 14, 2024
SELL
$3.51 - $4.69 $873,733 - $1.17 Million
-248,927 Reduced 70.29%
105,206 $382,000
Q2 2023

Aug 14, 2023
SELL
$3.51 - $4.69 $873,733 - $1.17 Million
-248,927 Reduced 70.29%
105,206 $382,000
Q1 2023

May 14, 2024
BUY
$3.58 - $6.3 $132,123 - $232,507
36,906 Added 11.63%
354,133 $1.53 Million
Q1 2023

May 11, 2023
BUY
$3.58 - $6.3 $132,123 - $232,507
36,906 Added 11.63%
354,133 $1.53 Million
Q4 2022

May 14, 2024
BUY
$3.18 - $7.0 $52,129 - $114,751
16,393 Added 5.45%
317,227 $2.22 Million
Q4 2022

Feb 13, 2023
BUY
$3.18 - $7.0 $52,129 - $114,751
16,393 Added 5.45%
317,227 $2.22 Million
Q3 2022

May 14, 2024
BUY
$2.37 - $4.28 $600,159 - $1.08 Million
253,232 Added 531.98%
300,834 $1.09 Million
Q3 2022

Nov 10, 2022
BUY
$2.37 - $4.28 $600,159 - $1.08 Million
253,232 Added 531.98%
300,834 $0
Q2 2022

May 14, 2024
SELL
$1.23 - $3.25 $422,541 - $1.12 Million
-343,530 Reduced 87.83%
47,602 $155,000
Q2 2022

Aug 15, 2022
SELL
$1.23 - $3.25 $459,786 - $1.21 Million
-373,810 Reduced 88.7%
47,602 $155,000
Q1 2022

May 16, 2022
BUY
$2.0 - $3.28 $617,932 - $1.01 Million
308,966 Added 274.77%
421,412 $843,000
Q4 2021

Feb 14, 2022
BUY
$3.14 - $5.15 $94,454 - $154,917
30,081 Added 36.52%
112,446 $354,000
Q3 2021

Nov 10, 2021
BUY
$4.89 - $7.12 $402,764 - $586,438
82,365 New
82,365 $403,000

Others Institutions Holding WVE

# of Institutions
205
Shares Held
125M
Call Options Held
499K
Put Options Held
180K
View Full List

About Wave Life Sciences Ltd.

WVE Quotes by TradingView
  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $606M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email